MA35947B1 - Anti-lgr5 antibodies and immunoconjugates - Google Patents

Anti-lgr5 antibodies and immunoconjugates

Info

Publication number
MA35947B1
MA35947B1 MA37448A MA37448A MA35947B1 MA 35947 B1 MA35947 B1 MA 35947B1 MA 37448 A MA37448 A MA 37448A MA 37448 A MA37448 A MA 37448A MA 35947 B1 MA35947 B1 MA 35947B1
Authority
MA
Morocco
Prior art keywords
immunoconjugates
lgr5 antibodies
lgr5
antibodies
methods
Prior art date
Application number
MA37448A
Other languages
French (fr)
Inventor
Yan Wu
Wei-Ching Liang
Jo-Anne Hongo
Weiguang Mao
Paul Polakis
Andrew Polson
Rajesh Vij
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/034629 external-priority patent/WO2013149159A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MA35947B1 publication Critical patent/MA35947B1/en

Links

Abstract

L'invention concerne des anticorps et des immunoconjugués anti-lgr5 et leurs procédés d'utilisation.The present invention relates to anti-lgr5 antibodies and immunoconjugates and methods of use thereof.

MA37448A 2012-03-30 2014-10-22 Anti-lgr5 antibodies and immunoconjugates MA35947B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261618232P 2012-03-30 2012-03-30
PCT/US2013/034629 WO2013149159A1 (en) 2012-03-30 2013-03-29 Anti-lgr5 antibodies and immunoconjugates

Publications (1)

Publication Number Publication Date
MA35947B1 true MA35947B1 (en) 2014-12-01

Family

ID=53758584

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37448A MA35947B1 (en) 2012-03-30 2014-10-22 Anti-lgr5 antibodies and immunoconjugates

Country Status (1)

Country Link
MA (1) MA35947B1 (en)

Similar Documents

Publication Publication Date Title
MA37538A2 (en) Anti-Ly6 antibodies and immunoconjugates and methods of use
MA35712B1 (en) Anti-htra1 antibodies and methods of use
MA35898B1 (en) Anti-lrp5 Antibodies and Methods of Use
MA39095A1 (en) Anti-cd33 antibodies and immunoconjugates
MA34818B1 (en) ANTI-PCSK9 ANTIBODIES AND METHODS OF USE
MA40682B1 (en) Anti-ox40 antibodies and methods of use thereof
MA43187B1 (en) Subcutaneous anti-cd38 antibody formulations and their uses
MA34881B1 (en) ANTIBODIES AND ANTI-MESOTHELIN IMMUNOCONJUGATES
MA40576B1 (en) Anti-her2 antibodies and immunoconjugates
MA43018B1 (en) Anti-pd1 antibodies and methods of use
MA40671A1 (en) Anti-c10orf54 Antibodies and Their Uses
MA38632B1 (en) Anti-transferrin receptor antibodies and methods of use
MA37840A3 (en) Immunoconjugates comprising anti-cd79b antibodies
MA39248B1 (en) Anti-jagged1 antibodies and methods of use thereof
MA44637B1 (en) Heterocyclic compounds and their uses
MA38686A1 (en) Teichoic acid antibodies to the cell wall and associated conjugates
EA201491811A1 (en) ANTI-LgR5 ANTIBODIES AND IMMUNOCONJUGATES
UY34721A (en) ANTI-HLA-B * 27 ANTIBODIES AND USES OF THESE.
EA201590173A1 (en) IMMUNOCONGUTS CONTAINING ANTIBODIES TO CD22
BR112014031310A2 (en) anti-pcsk9 antibodies, formulations, dosage and methods of use
MA34722B1 (en) METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY OF NEURAL DISEASES
MA44550B1 (en) Cell Wall Anti-Teichoic Acid Antibodies and Associated Conjugates
MA34541B1 (en) ANTIBODY COMPOSITIONS AND METHODS OF USE
MA39355B2 (en) Anti-ox40 antibodies and methods of use thereof
MA37643A1 (en) containers